Clinical Trials · NCT00363285
Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
- Phase
- Phase 3
- Recruitment status
- Unknown
- Sponsor
- St. Bartholomew's Hospital
- Enrollment
- 900
- Start date
- Jan 2003
- Locations
- 2 sites, United Kingdom
- Primary endpoint
- Time to loss of androgen-dependence, based on serum prostate-specific antigen (PSA) failure according to protocol definition